HK1126684A1 - Novel composition - Google Patents

Novel composition

Info

Publication number
HK1126684A1
HK1126684A1 HK09105851.8A HK09105851A HK1126684A1 HK 1126684 A1 HK1126684 A1 HK 1126684A1 HK 09105851 A HK09105851 A HK 09105851A HK 1126684 A1 HK1126684 A1 HK 1126684A1
Authority
HK
Hong Kong
Prior art keywords
novel composition
formoterol
budesonide
formulation
treatment
Prior art date
Application number
HK09105851.8A
Other languages
English (en)
Inventor
Nayna Govind
Maria Marlow
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20286853&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1126684(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HK1126684A1 publication Critical patent/HK1126684A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Stabilization Of Oscillater, Synchronisation, Frequency Synthesizers (AREA)
  • Networks Using Active Elements (AREA)
HK09105851.8A 2002-02-01 2009-06-30 Novel composition HK1126684A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0200312A SE0200312D0 (sv) 2002-02-01 2002-02-01 Novel composition

Publications (1)

Publication Number Publication Date
HK1126684A1 true HK1126684A1 (en) 2009-09-11

Family

ID=20286853

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09105851.8A HK1126684A1 (en) 2002-02-01 2009-06-30 Novel composition

Country Status (28)

Country Link
US (8) US7759328B2 (es)
EP (2) EP1474117B1 (es)
JP (2) JP2005521663A (es)
KR (2) KR100947168B1 (es)
CN (1) CN1287774C (es)
AT (2) ATE423552T1 (es)
AU (1) AU2003206289B2 (es)
BR (1) BR0307193A (es)
CA (1) CA2474479C (es)
CO (1) CO5611098A2 (es)
CY (2) CY1109030T1 (es)
DE (2) DE60332067D1 (es)
DK (2) DK1474117T3 (es)
ES (2) ES2342509T3 (es)
HK (1) HK1126684A1 (es)
IL (1) IL163160A (es)
IS (2) IS7360A (es)
MX (1) MXPA04007295A (es)
NO (1) NO337006B1 (es)
NZ (1) NZ534452A (es)
PL (1) PL211836B1 (es)
PT (2) PT2036549E (es)
RU (1) RU2301673C2 (es)
SE (1) SE0200312D0 (es)
SI (2) SI2036549T1 (es)
UA (1) UA79445C2 (es)
WO (1) WO2003063842A1 (es)
ZA (1) ZA200406086B (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0200312D0 (sv) * 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
US9084799B2 (en) 2005-02-11 2015-07-21 Pulmagen Therapeutics (Synergy) Limited Inhaled combination therapy
WO2006085102A1 (en) * 2005-02-11 2006-08-17 Argenta Discovery Limited Combination of methylxanthine compounds and steroids to treat chronic respiratory diseases
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
GB0604141D0 (en) * 2006-03-01 2006-04-12 Arrow Int Ltd Nebulizer formulation
GB0712454D0 (en) * 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
US20130160761A1 (en) * 2008-11-04 2013-06-27 Cipla Limited Pharmaceutical Aerosol Composition
NZ574666A (en) * 2009-02-05 2009-04-30 Nexus6 Ltd A medicament inhaler holder that uses optical means to count and display the number of doses used
JP5670421B2 (ja) 2009-03-31 2015-02-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング コンポーネント表面のコーティング方法
EP2432531B1 (de) 2009-05-18 2019-03-06 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
CA2781792C (en) 2009-11-25 2019-04-02 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
WO2011160932A1 (en) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nebulizer
US20130274232A1 (en) * 2010-07-16 2013-10-17 Cipla Limited Pharmaceutical Compositions
KR101803121B1 (ko) * 2010-08-03 2017-11-29 키에시 파르마슈티시 엣스. 피. 에이. 포스포디에스테라제 억제제를 포함하는 약학적 제제
US8574630B2 (en) * 2010-09-22 2013-11-05 Map Pharmaceuticals, Inc. Corticosteroid particles and method of production
US20120204871A1 (en) 2011-02-10 2012-08-16 Julio Cesar Vega Stable, non-corrosive formulations for pressurized metered dose inhalers
TWI399202B (zh) * 2011-03-17 2013-06-21 Intech Biopharm Ltd 製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
US9241904B1 (en) 2011-08-19 2016-01-26 Intech Biopharm Ltd. Method for preparing metered dose sprayed inhaler for treating respiratory disease
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
EP3030298B1 (en) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Nebulizer
PL2835146T3 (pl) 2013-08-09 2021-04-06 Boehringer Ingelheim International Gmbh Nebulizator
GB201321712D0 (en) 2013-12-09 2014-01-22 Pharmachemie Bv Dry Powder Inhaler
GB201321717D0 (en) 2013-12-09 2014-01-22 Pharmachemie Bv Inhalable Medicaments
US10195374B2 (en) 2014-05-07 2019-02-05 Boehringer Ingelheim International Gmbh Container, nebulizer and use
ES2913297T3 (es) 2014-05-07 2022-06-01 Boehringer Ingelheim Int Nebulizador
US10722666B2 (en) 2014-05-07 2020-07-28 Boehringer Ingelheim International Gmbh Nebulizer with axially movable and lockable container and indicator
EP3174522A1 (en) * 2014-07-29 2017-06-07 3M Innovative Properties Company Method of preparing a pharmaceutical composition
ES2866175T3 (es) 2015-12-04 2021-10-19 Mexichem Fluor Sa De Cv Composición farmacéutica
CN106581010B (zh) * 2016-12-28 2019-03-05 四川普锐特医药科技有限责任公司 一种气溶胶制剂及定量吸入气雾剂
EP3668505A4 (en) 2017-08-15 2021-05-12 Nephron Pharmaceuticals Corporation Aqueous fogging composition
US11756656B2 (en) 2018-06-14 2023-09-12 Astrazeneca Uk Limited Methods for treating and preventing symptoms of asthma with a corticosteroid pharmaceutical composition
JP7402631B2 (ja) 2018-08-27 2023-12-21 帝人株式会社 極細炭素繊維混合物、その製造方法、及び炭素系導電助剤
CN109464429B (zh) * 2018-12-13 2021-04-27 上海方予健康医药科技有限公司 一种吸入压力定量气雾剂药物组合物及其制备方法
CN112137957B (zh) 2019-06-26 2022-07-29 长风药业股份有限公司 一种药用吸入气雾剂及其制备方法
CN112972384B (zh) * 2019-12-02 2022-03-18 长风药业股份有限公司 一种格隆溴铵和茚达特罗原料药微粉混合物的制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6123924A (en) * 1991-09-25 2000-09-26 Fisons Plc Pressurized aerosol inhalation compositions
IL103238A (en) 1991-09-25 1995-07-31 Fisons Plc Pressed aerosol preparations
HU0004452D0 (es) 1991-12-18 2001-01-29 Astra Ab
DE19536902A1 (de) * 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
SE9603669D0 (sv) 1996-10-08 1996-10-08 Astra Ab New combination
AU722859B2 (en) 1996-11-11 2000-08-10 Sepracor, Inc. Process for the preparation of optically pure isomers of formoterol
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
US6309623B1 (en) * 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
SE9802073D0 (sv) * 1998-06-11 1998-06-11 Astra Ab New use
DE59911149D1 (de) 1998-07-24 2004-12-30 Jago Res Ag Muttenz Medizinische aerosolformulierungen
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
SE9900834D0 (sv) 1999-03-09 1999-03-09 Astra Ab Novel combination
PE20011227A1 (es) 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
GB0009584D0 (en) 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
GB0012260D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
GB0016876D0 (en) 2000-07-11 2000-08-30 Astrazeneca Ab Novel formulation
US20030018019A1 (en) * 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
SE0200312D0 (sv) * 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition

Also Published As

Publication number Publication date
US8143239B2 (en) 2012-03-27
SI2036549T1 (sl) 2010-07-30
KR100947168B1 (ko) 2010-03-12
AU2003206289B2 (en) 2007-09-06
RU2004122921A (ru) 2005-06-10
ATE463241T1 (de) 2010-04-15
NO20043458L (no) 2004-08-19
ATE423552T1 (de) 2009-03-15
US20100275913A1 (en) 2010-11-04
IS2960B (is) 2017-02-15
IL163160A (en) 2013-12-31
DK2036549T3 (da) 2010-07-12
CY1110081T1 (el) 2015-01-14
US20170368078A1 (en) 2017-12-28
ZA200406086B (en) 2006-01-25
UA79445C2 (en) 2007-06-25
SE0200312D0 (sv) 2002-02-01
CY1109030T1 (el) 2014-07-02
CO5611098A2 (es) 2006-02-28
DE60326320D1 (de) 2009-04-09
US8575137B2 (en) 2013-11-05
JP2005521663A (ja) 2005-07-21
NO337006B1 (no) 2015-12-21
CA2474479C (en) 2011-04-05
US20190216828A1 (en) 2019-07-18
ES2321180T3 (es) 2009-06-03
EP1474117A1 (en) 2004-11-10
DK1474117T3 (da) 2009-05-25
KR20090125857A (ko) 2009-12-07
EP1474117B1 (en) 2009-02-25
WO2003063842A9 (en) 2004-04-22
IS7360A (is) 2004-07-21
RU2301673C2 (ru) 2007-06-27
US10166247B2 (en) 2019-01-01
US20210069215A1 (en) 2021-03-11
WO2003063842A1 (en) 2003-08-07
EP2036549A1 (en) 2009-03-18
KR20040081757A (ko) 2004-09-22
CN1625392A (zh) 2005-06-08
US7759328B2 (en) 2010-07-20
NZ534452A (en) 2006-01-27
PT1474117E (pt) 2009-04-24
US20050089478A1 (en) 2005-04-28
PT2036549E (pt) 2010-06-22
IS9028A (is) 2013-04-16
CN1287774C (zh) 2006-12-06
US11311558B2 (en) 2022-04-26
JP5259636B2 (ja) 2013-08-07
US20160022703A1 (en) 2016-01-28
US20140286878A1 (en) 2014-09-25
PL372118A1 (en) 2005-07-11
DE60332067D1 (de) 2010-05-20
ES2342509T3 (es) 2010-07-07
SI1474117T1 (sl) 2009-06-30
MXPA04007295A (es) 2004-10-29
PL211836B1 (pl) 2012-06-29
US20120216802A1 (en) 2012-08-30
EP2036549B1 (en) 2010-04-07
BR0307193A (pt) 2004-11-03
CA2474479A1 (en) 2003-08-07
JP2010132695A (ja) 2010-06-17

Similar Documents

Publication Publication Date Title
IS2960B (is) Ný efnablanda
SI2042168T1 (sl) Inhalacijska formulacija, ki obsega fenetanolaminske derivate, za zdravljenje respiratornih bolezni
AU2003264282A1 (en) Phenethanolamine derivatives and their use in the treatment of respiratory diseases
HK1151987A1 (en) Pharmaceutical compositions for the treatment of asthma
AU2003300939A8 (en) Methods for the treatment of pain and traumatic injury using benzamides and compositions containing the same
MY134222A (en) NEW MEDICAMENT COMPOSITIONS BASED ON ANTICHOLINERGICALLY-EFFECTIVE COMPOUNDS AND ß-MIMETICS
EP1478276A4 (en) NEW TARGETED COMPOSITIONS FOR DIAGNOSTIC AND THERAPEUTIC USE
HUP0201834A3 (en) Use of thyromimetic compounds for the manufacture of a pharmaceutical composition for the treatment of hair loss and such compositions
SG148194A1 (en) Compositions for the treatment of affections of the oral cavity and upper respiratory tract
IL166363A0 (en) 1-phenyl-2-dimethylaminomethyl cyclohexane compounds used for the therapy of depressive symptoms pa in and incontinence
IL168308A (en) Compositions containing roflumilast and formoterol
PL1670482T3 (pl) Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego
IL157144A0 (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
EP1406600A4 (en) COMPOSITIONS AND METHOD FOR THE ADMINISTRATION OF TUBULIN BINDING AGENTS FOR THE TREATMENT OF EYE DISEASES
EP1677745A4 (en) NITRON COMPOUND PRODRUGS AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF HUMAN DISEASES
IL165574A0 (en) Compositions for the transport of therapeutic molecules into the lungs and use thereof for the treatment of lung cancers and pulmonary diseases
AU2002325687A1 (en) Pharmaceutical composition comprising salmeterol and budesonide for the treatment of respiratory disorders
HU0203447D0 (en) Use of polysaccharide-sulfuric acid-derivatives for preparing pharmaceutical composition effective for curing psoriasis and other skin diseases
HUP0202416A3 (en) Novel pharmaceutical combination and it's use for the treatment of certain cardiovascular disorders
IL159581A0 (en) Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases
SI1670482T2 (sl) Uporaba ciklezonida za zdravljenje respiratornih bolezni

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20230128